Olema Pharmaceuticals Inc

NASDAQ:OLMA   3:59:58 PM EDT
11.05
+0.55 (+5.24%)
Earnings Announcements

Olema Oncology Reports Q3 2021 Financial Results

Published: 11/10/2021 22:45 GMT
Olema Pharmaceuticals Inc (OLMA) - Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Qtrly Loss per Share 45 Cents.
Q3 Earnings per Share View $-0.46 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.51

More details on our Analysts Page.